JP2022535956A5 - - Google Patents

Info

Publication number
JP2022535956A5
JP2022535956A5 JP2021573382A JP2021573382A JP2022535956A5 JP 2022535956 A5 JP2022535956 A5 JP 2022535956A5 JP 2021573382 A JP2021573382 A JP 2021573382A JP 2021573382 A JP2021573382 A JP 2021573382A JP 2022535956 A5 JP2022535956 A5 JP 2022535956A5
Authority
JP
Japan
Prior art keywords
alkyl
disease
compound
disorder
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021573382A
Other languages
English (en)
Japanese (ja)
Other versions
JP7682813B2 (ja
JP2022535956A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/066191 external-priority patent/WO2020249667A1/en
Publication of JP2022535956A publication Critical patent/JP2022535956A/ja
Publication of JP2022535956A5 publication Critical patent/JP2022535956A5/ja
Application granted granted Critical
Publication of JP7682813B2 publication Critical patent/JP7682813B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021573382A 2019-06-12 2020-06-11 スルホニル尿素誘導体及びその使用 Active JP7682813B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962860663P 2019-06-12 2019-06-12
US62/860,663 2019-06-12
PCT/EP2020/066191 WO2020249667A1 (en) 2019-06-12 2020-06-11 Sulfonylurea derivatives and uses thereof

Publications (3)

Publication Number Publication Date
JP2022535956A JP2022535956A (ja) 2022-08-10
JP2022535956A5 true JP2022535956A5 (enExample) 2023-06-19
JP7682813B2 JP7682813B2 (ja) 2025-05-26

Family

ID=71108563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573382A Active JP7682813B2 (ja) 2019-06-12 2020-06-11 スルホニル尿素誘導体及びその使用

Country Status (16)

Country Link
US (1) US12054461B2 (enExample)
EP (1) EP3983387B1 (enExample)
JP (1) JP7682813B2 (enExample)
CN (1) CN114641466B (enExample)
DK (1) DK3983387T3 (enExample)
ES (1) ES2983661T3 (enExample)
FI (1) FI3983387T3 (enExample)
HR (1) HRP20240896T1 (enExample)
HU (1) HUE067378T2 (enExample)
LT (1) LT3983387T (enExample)
PL (1) PL3983387T3 (enExample)
PT (1) PT3983387T (enExample)
RS (1) RS65711B1 (enExample)
SI (1) SI3983387T1 (enExample)
SM (1) SMT202400291T1 (enExample)
WO (1) WO2020249667A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
CN114641466B (zh) 2019-06-12 2025-09-30 诺瑟拉有限公司 磺酰脲衍生物及其用途
KR102802013B1 (ko) * 2021-02-03 2025-05-07 환인제약 주식회사 알츠하이머병 치료를 위한 nlrp3 인플라마좀 소분자 억제제

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2110689A (en) 1981-12-03 1983-06-22 Sandoz Ltd Herbicidal heterocyclic aminosulfonyl ureas and isoureas
CH649081A5 (de) 1982-01-12 1985-04-30 Ciba Geigy Ag Triaza-verbindungen.
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JPS60214785A (ja) * 1984-03-27 1985-10-28 Nissan Chem Ind Ltd ピラゾ−ルスルホニルウレア誘導体、および植物生長調節剤または除草剤
US5214206A (en) 1990-11-07 1993-05-25 Warner-Lambert Company Aminosulfonyl urea acat inhibitors
WO1993004045A1 (en) 1991-08-19 1993-03-04 E.I. Du Pont De Nemours And Company Angiotensin ii receptor blocking imidazolinone derivatives
AU2494792A (en) 1991-08-19 1993-03-16 E.I. Du Pont De Nemours And Company Angiotensin ii receptor blocking imidazolinone derivatives
NZ247440A (en) 1992-05-06 1995-04-27 Squibb & Sons Inc Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
DE4217719A1 (de) * 1992-05-29 1993-12-02 Bayer Ag Zweifach heterocyclisch substituierte Sulfonylamino(thio)carbonylverbindungen
DE4302702A1 (de) 1993-02-01 1994-08-04 Bayer Ag Arylaminosulfonylharnstoffe
DE4302701A1 (de) 1993-02-01 1994-08-04 Bayer Ag Arylaminosulfonylharnstoffe
JP3355237B2 (ja) * 1993-10-15 2002-12-09 呉羽化学工業株式会社 N−(置換アミノ)ピロール誘導体、その製造方法及び除草剤
JPH0827147A (ja) * 1994-07-20 1996-01-30 Kureha Chem Ind Co Ltd N−(置換アミノ)イミド誘導体、その製造方法及び除草剤
JPH09132574A (ja) 1995-11-09 1997-05-20 Nissan Chem Ind Ltd フルオロプロピルチアゾリン誘導体の製造法
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
US6028201A (en) 1996-01-30 2000-02-22 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
WO1998000408A1 (en) 1996-07-02 1998-01-08 Novartis Ag N-phenylimino heterocyclic derivatives and their use as herbicides
JPH1029990A (ja) 1996-07-12 1998-02-03 Kureha Chem Ind Co Ltd 1−(置換アミノ)イミダゾール誘導体、その製造方法及び除草剤
DE19651037A1 (de) 1996-12-09 1998-06-10 Bayer Ag Substituierte Thienyl(amino)sulfonyl(thio)harnstoffe
AU723895B2 (en) 1997-01-29 2000-09-07 Pfizer Inc. Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
IT1290062B1 (it) 1997-03-13 1998-10-19 Isagro Ricerca Srl Amminosolfoniluree ad attivita' erbicida
GB9909409D0 (en) 1999-04-24 1999-06-23 Zeneca Ltd Chemical compounds
DE19937118A1 (de) 1999-08-06 2001-02-08 Bayer Ag Substituierte Thienyl(amino)sulfonylharnstoffe
JP4112127B2 (ja) 1999-08-31 2008-07-02 株式会社リコー 感熱記録材料
AU7447500A (en) 1999-09-30 2001-04-30 Mitsubishi Chemical Corporation Acylsulfonamide derivatives
US6593356B2 (en) 1999-10-20 2003-07-15 Bristol-Myers Squibb Pharma Company Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
EP1281399A3 (en) 2001-08-01 2004-02-11 Warner-Lambert Company Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
WO2003029226A1 (en) 2001-09-26 2003-04-10 Basf Aktiengesellschaft Heterocyclyl substituted phenoxyalkyl-, phenylthioalkyl-, phenylaminoalkyl- and phenylalkyl-sulfamoylcarboxamides
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US20070191336A1 (en) 2003-12-24 2007-08-16 Flynn Daniel L Anti-inflammatory medicaments
AU2005325676A1 (en) 2004-12-23 2006-08-03 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
WO2009086303A2 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
CN104245696A (zh) 2012-02-07 2014-12-24 凯诺斯医药公司 作为1型二酰基甘油o-酰基转移酶的抑制剂的化合物
CN103288750A (zh) 2013-03-04 2013-09-11 盐城工学院 新型氨基磺酰脲类化合物
US9410217B2 (en) 2014-02-18 2016-08-09 Renmatix, Inc. Method of reducing a fermentation and/or enzyme inhibitor in a saccharide-containing composition
KR102727059B1 (ko) 2015-02-16 2024-11-05 더 유니버서티 어브 퀸슬랜드 설포닐우레아와 관련 화합물 및 그 용도
CN109071454B (zh) * 2016-02-16 2023-02-17 昆士兰大学 磺酰脲和相关化合物及其用途
WO2017189663A1 (en) 2016-04-26 2017-11-02 Enanta Pharmaceuticals, Inc. Isoxazole derivatives as fxr agonists and methods of use thereof
US10080741B2 (en) 2016-04-26 2018-09-25 Enanta Pharmaceuticals, Inc. Isoxazole derivatives as FXR agonists and methods of use thereof
WO2017189651A1 (en) 2016-04-26 2017-11-02 Enanta Pharmaceuticals, Inc. Isoxazole derivatives as fxr agonists and methods of use thereof
US10144729B2 (en) 2016-05-18 2018-12-04 Enanta Pharmaceuticals, Inc. Isoxazole analogs as FXR agonists and methods of use thereof
WO2017201152A1 (en) 2016-05-18 2017-11-23 Enanta Pharmaceuticals, Inc. Isoxazole derivatives as fxr agonists and methods of use thereof
WO2017201155A1 (en) 2016-05-18 2017-11-23 Enanta Pharmaceuticals, Inc. lSOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF
EP3272739A1 (en) 2016-07-20 2018-01-24 NodThera Limited Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
RS65492B1 (sr) 2017-07-24 2024-05-31 Novartis Ag Jedinjenja i kompozicije za lečenje stanja povezanih sa aktivnošću nlrp
EP3668861A1 (en) * 2017-08-15 2020-06-24 Inflazome Limited Novel sulfonamide carboxamide compounds
US11518739B2 (en) 2017-08-15 2022-12-06 Inflazome Limited Sulfonamide carboxamide compounds
MX2020001776A (es) 2017-08-15 2020-03-24 Inflazome Ltd Sulfonilureas y sulfoniltioureas como inhibidores de nlrp3.
JP2020531448A (ja) 2017-08-15 2020-11-05 インフレイゾーム リミテッド 新規なスルホンアミドカルボキサミド化合物
WO2019034693A1 (en) 2017-08-15 2019-02-21 Inflazome Limited SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3
EP3668862A1 (en) 2017-08-15 2020-06-24 Inflazome Limited Novel sulfonamide carboxamide compounds
US11542255B2 (en) 2017-08-15 2023-01-03 Inflazome Limited Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
GB201902327D0 (en) * 2019-02-20 2019-04-03 Inflazome Ltd Novel compounds
US12187702B2 (en) * 2018-08-15 2025-01-07 Inflazome Limited Sulfonamideurea compounds
CN114641466B (zh) 2019-06-12 2025-09-30 诺瑟拉有限公司 磺酰脲衍生物及其用途
CN114761383A (zh) 2019-06-12 2022-07-15 诺瑟拉有限公司 磺酰胺衍生物及其用途
CN114222739B (zh) 2019-06-12 2025-02-11 诺瑟拉有限公司 磺酰脲衍生物及其用途
CN116783184A (zh) 2020-09-04 2023-09-19 诺瑟拉有限公司 含有烷基-氧杂环烷基部分的氨磺酰基脲衍生物及其用途

Similar Documents

Publication Publication Date Title
JP2022535956A5 (enExample)
JP2022536160A5 (enExample)
JP2023540733A5 (enExample)
TW202204323A (zh) 經取代之嗒𠯤化合物
CN103347509B (zh) 用于治疗癌症的化合物和组合物
JP2014513046A5 (enExample)
RS62164B1 (sr) Sulfoniluree i srodna jedinjenja i njihova upotreba
HRP20250964T1 (hr) Derivati sulfonil ureje kao modulatori nlrp3 inflamasoma
JP2021532124A (ja) Nlrp3インフラマソーム阻害剤
JP2021522276A5 (enExample)
JP2018510207A5 (enExample)
JP2018531289A5 (enExample)
CN103370289A (zh) 4-羟基丁酸氘化类似物
JP2019533642A5 (enExample)
JP7200005B2 (ja) 飽和環縮合ジヒドロピリミジノン又はジヒドロトリアジノン化合物及びその医薬用途
TW201900628A (zh) Atf3誘導化合物
JP2022535955A5 (enExample)
HRP20240896T1 (hr) Derivati sulfoniluree i njihova upotreba
JP2022518526A5 (enExample)
AU2019314323B2 (en) Sulfopropanoic acid derivatives for treating neurodegenerative disorders
JP2025504374A5 (enExample)
JP2022522890A5 (enExample)
TW201414707A (zh) 3,5,n-三羥烷醯胺及其衍生物、其之製造方法與用途
RU2023108168A (ru) Производные сульфамоилмочевины, содержащие алкилоксациклоалкильную группу, и их применения
JP2021522295A5 (enExample)